Skip to main content
Access every election story that matters
Enjoy unlimited digital access
$1.99
per week for 24 weeks
Access every election story that matters
Enjoy unlimited digital access
$1.99
per week
for 24 weeks
// //

Nurses prepare vaccination cards for vaccinated locals on July 9 in Harare, Zimbabwe. The Zimbabwe government is using vaccines from Russia and China to protect the population from COVID-19.

Tafadzwa Ufumeli/Getty Images

Retired teacher Tavaguma Zipiti remembers how he mocked his friends when they rushed to the queues to get vaccinated. He was convinced that the Chinese-made doses in Zimbabwe were too risky to take.

But then COVID-19 swept through his family. His wife, his son and his daughter-in-law – all grew sick and died. He saw many others dying. So he joined the vaccination rush. “I desperately need the vaccine,” he said recently as he stood in a winding 300-metre queue outside a hospital in Harare. “I’m afraid now.”

As deaths and illnesses escalate, Zimbabweans are increasingly frantic to get vaccinated. But the lineups are growing longer, the wait can be exhausting and many people are turned away. Some say they are resorting to unofficial methods to jump the queues: bribes or political connections. Others pay hefty fees at private clinics to get faster access.

Story continues below advertisement

Canada’s and Zimbabwe’s paths for COVID-19 vaccination are worlds apart

Driven by Delta variant, COVID-19 surges across Africa

“I was here at 4 a.m.,” said 26-year-old Tracy Nechavava, one of 300 people waiting for vaccination at Parirenyatwa General Hospital in Harare. “Now it’s after 1 p.m., and I haven’t received the jab yet. Some are saying the vaccine isn’t even here yet. I’m tired, but I have no choice. I need the vaccine, because people are dying.”

Eight months after vaccines arrived in wealthy countries, the global vaccine shortage is persisting. While most people in rich countries have received at least one dose of vaccine by now, lower-income countries still have severe shortages. Only 4 per cent of Africans have received any vaccine, even as the pandemic surges into a third or fourth wave in many countries on the continent.

A family watches pallbearers carry the coffin of a relative who died from COVID-19 at a cemetery in Harare on July 15. Zimbabwe has one of the highest vaccination rates in Africa, but even here only 5 per cent of the population is fully vaccinated, primarily with Chinese vaccines.

Tsvangirayi Mukwazhi/The Associated Press

And now there’s a new threat to the global supply: booster shots. A number of wealthy countries are securing doses for potential third shots, despite unclear evidence on whether they are needed. The race to acquire booster-shot contracts is damaging the desperately needed supply for poorer countries.

The World Health Organization is calling for a moratorium on all booster shots until the end of September at least, so that poorer countries can reach the minimum goal of a 10-per-cent vaccination rate.

“Even while hundreds of millions of people are still waiting for their first dose, some rich countries are moving towards booster doses,” WHO director-general Tedros Adhanom Ghebreyesus said at a briefing on Wednesday.

“We cannot accept countries that have already used most of the global supply of vaccines using even more of it while the world’s most vulnerable people remain unprotected,” he said.

Last week, Israel became the first country to begin administering a third vaccine dose, offering the booster to people over the age of 60. Germany, meanwhile, has announced it will offer Pfizer and Moderna booster shots in September to older people and other vulnerable groups, and to anyone vaccinated with the AstraZeneca or Johnson & Johnson vaccines, which are considered less protective. Several other European countries are also planning to offer booster shots.

Story continues below advertisement

An Israeli woman receives a third coronavirus vaccine injection at a senior centre in Jerusalem on Aug. 4. Israeli health authorities have begun administering coronavirus booster shots to people over 60 who've already received both doses of a vaccine, in a bid to combat a recent spike in cases.

Maya Alleruzzo/The Associated Press

In Canada, Prime Minister Justin Trudeau announced in April that the government has secured an agreement with Pfizer for 35 million booster shots next year and 30 million the year after. And Quebec has offered a third shot of Pfizer or Moderna to anyone travelling to a country where the Indian-made AstraZeneca vaccine is not accepted in entry requirements.

On average, Dr. Tedros said, high-income countries have administered almost 100 doses for every 100 people – twice as many as in May. But low-income countries have been able to administer only 1.5 doses for every 100 people because of the supply crisis.

“We need an urgent reversal,” Dr. Tedros told the media briefing on Wednesday.

For Zimbabweans and other Africans, the notion of a booster shot is a remote dream. Most are struggling to get even one jab of a COVID-19 vaccine. “Citizens bear the brunt of the shortages across vaccination centres in the country,” the Zimbabwe Democracy Institute said in a recent report on the situation.

Zimbabwe has one of the highest vaccination rates in Africa, but even here only 5 per cent of the population is fully vaccinated, primarily with Chinese vaccines.

People wait to be vaccinated at Leopold Sedar Senghor stadium in Dakar, Senegal, on July 28. For Zimbabweans and other Africans, the notion of a booster shot is a remote dream. Most are struggling to get even one jab of a COVID-19 vaccine.

Leo Correa/The Associated Press

“If I don’t get vaccinated today, I’m giving up,” said Thembani Chin’ombe, a 57-year-old man in the crowded queue at Parirenyatwa hospital in Harare.

Story continues below advertisement

On two earlier days, he had joined the vaccine queue without success. “This is the third time I’m facing this frustration,” he told The Globe and Mail. “I have no money to bribe the nurses to let me jump the queue, as I’ve seen many others doing.”

Faced with the huge lines, many Zimbabweans are using any possible trick to get a vaccine. One man, Kundai Njovo, said he gave five U.S. dollars to a nurse so that he could bypass the queue. “I’m busy, I can’t wait longer,” he said.

Another man, Tererai Zizhou, said he skipped the line by showing a nurse his membership card in Zimbabwe’s ruling party, ZANU-PF. “If people stranded in these queues had ZANU-PF cards, they would face no problems,” he said. “You support ZANU-PF, you gain access to everything.”

The vaccine shortage has created a two-tier system in Zimbabwe. Those with money have the privilege of faster service. At private clinics in affluent suburbs of Harare, people are paying US$40 to get the jab with only a short wait.

“It’s better than waiting forever at public hospitals,” Tobias Hamandishe, a private-school tutor, said as he visited a private clinic in the Mount Pleasant suburb. “It’s much faster here.”

Sign up for the Coronavirus Update newsletter to read the day’s essential coronavirus news, features and explainers written by Globe reporters and editors.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow the authors of this article:

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies